VHL: Trends and Insight into a Multi-Modality, Interdisciplinary Approach for Management of Central Nervous System...

Area of Science:

• Neuro-oncology
• Genetics
• Multisystemic disorders

Background:

• Von Hippel-Lindau (VHL) disease is a genetic disorder leading to tumors, notably CNS hemangioblastomas.
• CNS hemangioblastomas pose significant management challenges due to varied natural history, size, and location.
• Surgical resection is the primary treatment but carries substantial risks, especially for posterior fossa and spinal cord lesions.

Approach:

• Literature review and experience from two European VHL referral centers.
• Analysis of surgical, stereotactic radiosurgery, and evolving medical treatment modalities.
• Emphasis on a personalized, multimodal treatment strategy for CNS hemangioblastomas.

Key Points:

• CNS hemangioblastomas in VHL disease require tailored management.
• Stereotactic radiosurgery is an increasingly utilized adjunct to surgery.
• Medical therapies are evolving as potential future treatments.
• Multidisciplinary and holistic patient care is crucial for VHL management.

Conclusions:

• A personalized treatment approach combining multiple modalities is essential for CNS hemangioblastomas in VHL.
• Interdisciplinary collaboration and a holistic strategy are vital for managing VHL patients effectively.